Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overview of clinical studies of childhood acute lymphoblastic leukemia for more than ten years by the Japanese Children's Cancer and Leukemia Study Group.
Koizumi S, Fujimoto T, Oka T, Watanabe S, Kikuta A, Tsuchiya T, Matsushita T, Asami K, Yanase T, Mimaya J, Ohta S, Miyake M, Nishikawa K, Furuyama T, Yamamura Y, Takaue Y, Ninomiya T, Shimokawa T, Iwai A, Ishida Y, Ariyoshi N, Kimura K, Kawakami K, Gushiken T, Sekine I. Koizumi S, et al. Among authors: iwai a. Pediatr Hematol Oncol. 1997 Jan-Feb;14(1):17-28. doi: 10.3109/08880019709030881. Pediatr Hematol Oncol. 1997. PMID: 9021810 Review.
[Bone marrow relapse in high-risk pediatric patients with acute lymphoblastic leukemia: a comparison of relapse times and initial clinical features of patients on different protocols. Children's Cancer and Leukemia Study group (CCLSG)].
Tsurusawa M, Katano N, Hirota T, Koizumi S, Asami K, Chin M, Ota S, Kawakami T, Hatae Y, Sekine I, Iwai A, Anami K, Nishi K, Miyake M, Watanabe A, Yatabe M, Kawakami K, Gushi K, Yokota S, Gusiken T, Kikuta A, Mimaya J, Okada N, Iga M, Fujimoto T. Tsurusawa M, et al. Among authors: iwai a. Rinsho Ketsueki. 1998 Aug;39(8):565-73. Rinsho Ketsueki. 1998. PMID: 9785974 Clinical Trial. Japanese.
Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group.
Tsurusawa M, Katano N, Yamamoto Y, Hirota T, Koizumi S, Watanabe A, Takeda T, Hatae Y, Yatabe M, Mimaya J, Gushiken T, Nishi K, Anami K, Kikuta A, Kanegane H, Asami K, Nishikawa K, Sekine I, Kawano Y, Iwai A, Furuyama T, Ijichi O, Miyake M, Mugishima H, Fujimoto T, et al. Tsurusawa M, et al. Among authors: iwai a. Med Pediatr Oncol. 1999 Apr;32(4):259-6. doi: 10.1002/(sici)1096-911x(199904)32:4<259::aid-mpo4>3.0.co;2-3. Med Pediatr Oncol. 1999. PMID: 10102019 Clinical Trial.
Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia.
Nakamura A, Tsurusawa M, Kato A, Taga T, Hatae Y, Miyake M, Mimaya J, Onodera N, Watanabe A, Watanabe T, Kanegane H, Matsushita T, Iwai A, Hyakuna N, Gushi K, Kawakami T, Sekine I, Izichi O, Asami K, Kikuta A, Tanaka A, Fujimoto T; Children's Cancer and Leukemia Study Group. Nakamura A, et al. Among authors: iwai a. Leuk Lymphoma. 2001 Jul;42(3):393-8. doi: 10.3109/10428190109064596. Leuk Lymphoma. 2001. PMID: 11699404
Long-term results of the Japanese Childhood Cancer and Leukemia Study Group studies 811, 841, 874 and 911 on childhood acute lymphoblastic leukemia.
Tsurusawa M, Shimomura Y, Asami K, Kikuta A, Watanabe A, Horikoshi Y, Matsushita T, Kanegane H, Ohta S, Iwai A, Mugishima H, Koizumi S; Japanese Childhood Cancer and Leukemia Study Group. Tsurusawa M, et al. Among authors: iwai a. Leukemia. 2010 Feb;24(2):335-44. doi: 10.1038/leu.2009.259. Epub 2009 Dec 17. Leukemia. 2010. PMID: 20016539 Clinical Trial.
L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
Tsurusawa M, Chin M, Iwai A, Nomura K, Maeba H, Taga T, Higa T, Kuno T, Hori T, Muto A, Yamagata M; Japanese Children's Cancer and Leukemia Study Group. Tsurusawa M, et al. Among authors: iwai a. Cancer Chemother Pharmacol. 2004 Mar;53(3):204-8. doi: 10.1007/s00280-003-0734-5. Epub 2003 Nov 22. Cancer Chemother Pharmacol. 2004. PMID: 14634792 Clinical Trial.
Minimal residual disease-based augmented therapy in childhood acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Yamaji K, Okamoto T, Yokota S, Watanabe A, Horikoshi Y, Asami K, Kikuta A, Hyakuna N, Saikawa Y, Ueyama J, Watanabe T, Okada M, Taga T, Kanegane H, Kogawa K, Chin M, Iwai A, Matsushita T, Shimomura Y, Hori T, Tsurusawa M; Japanese Childhood Cancer Leukemia Study Group. Yamaji K, et al. Among authors: iwai a. Pediatr Blood Cancer. 2010 Dec 15;55(7):1287-95. doi: 10.1002/pbc.22620. Pediatr Blood Cancer. 2010. PMID: 20535816 Clinical Trial.
Assessment of late cardiotoxicity of pirarubicin (THP) in children with acute lymphoblastic leukemia.
Shimomura Y, Baba R, Watanabe A, Horikoshi Y, Asami K, Hyakuna N, Iwai A, Matsushita T, Yamaji K, Hori T, Tsurusawa M; Japanese Childhood Cancer and Leukemia Study Group (JCCLSG). Shimomura Y, et al. Among authors: iwai a. Pediatr Blood Cancer. 2011 Sep;57(3):461-6. doi: 10.1002/pbc.23012. Epub 2011 Feb 4. Pediatr Blood Cancer. 2011. PMID: 21298773 Clinical Trial.
271 results